Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019

Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.

Feb 13, 2019

The company will highlight expanded product offerings and other 3D applications in oncology, neuroscience, toxicity screening, and more. Corning experts will be able to speak to these applications, the impact of 3D in research and development and drug discovery, as well as perspectives in disease modeling and high-throughput screening. 

Discussion topics will include how the use of physiologically relevant 3D cell cultures is facilitating discovery and validation of novel drug targets and accelerating clinical translation of drug candidate screening for safety and efficacy. Spokespeople will be available for tours and to share insights at booth #413. 

Corning and its customers will also offer several presentations and posters during SLAS including: Presentations and Tutorials 

Sunday, February 3, 2019 
Short Course: Set-up and Validation of 3D Primary, Stem Cell and Immortalized Cultures for Downstream Microplate Reader and Imaging Applications Presented by: Brad Larson, BioTek Instruments, Inc., Mark E. Rothenberg Ph.D., Corning Life Sciences 8:00 a.m. – 12:00 p.m. Convention Center, room 143C 

Monday, February 4, 2019 
Tutorial: Spheroids and Mini Brains for Studying Glioblastoma Presented by: Amanda Linkous, Ph.D., NCI Center for Systems Biology of Small Cell Lung Cancer at Vanderbilt, Hilary Sherman, Corning Life Sciences 2:00 – 2:45 p.m. Convention Center, Room 151A

Tuesday, February 5, 2019
 Podium Presentation: Fully Automated Large Scale uHTS using 3D Cancer Organoid Models for Phenotypic Drug Discovery Applications Presented by: Virneliz Fernandez Vega, Scripps Research Institute 12:00 – 12:30 p.m. 

Wednesday, February 6, 2019 
Podium Presentation: High-throughput, CRISPR Based 3D Screening Platform for Rapid Discovery of Novel CDK4/6 Inhibitor Resistance Presented by: Taraka Sai Pavan Grandhi, Ph.D, Genomics Institute of Novartis Research Foundation 11:00 AM - 11:30 AM


Corning Life Sciences and its customers will be presenting several posters throughout the meeting including those focused on high-throughput screening, 3D assay development, air-liquid interface models and other 3D application areas. 

If you are interested in scheduling a booth tour and meeting with a member of the Corning team to learn more about how Corning is transforming and enabling the future of 3D with innovative technologies and workflow solutions, please contact:
Leanne Stone

July/August 2019

On Target

Researchers strive to make individualized medicine a reality


Sponsored Product Updates

Handbook of Assays for Developing Targeting Therapeutics
Handbook of Assays for Developing Targeting Therapeutics
Download this handbook from LI-COR Biosciences to learn about key assays used to answer vital questions related to therapeutics research, including Western blotting, protein profiling, tissue section microscopy, and in vivo and ex vivo imaging!
Why Less is More When it Comes to Ultra-Low Temperature Freezers
Why Less is More When it Comes to Ultra-Low Temperature Freezers
Download the latest application article to learn how replacing compressor-based ultra-low temperature freezers with more energy- and space-efficient Stirling Ultracold units delivers more overall cost savings while operating with a smaller carbon footprint.
Seven Tips to Improve Cell Counting Accuracy
Seven Tips to Improve Cell Counting Accuracy
Download this technical note to learn seven top tips to ensure accurate and reproducible results, whether counting cells manually or using automated systems!